WEBSITE BSE:544339 NSE: LAXMIDENTL Inc. Year: 2004 Industry: Medical Equipment/Supplies/Accessories My Bucket: Add Stock
Last updated: 15:56
Laxmi Dental Limited, established in 2004 and based in Mumbai, India, is a prominent player in the dental industry, providing a comprehensive range of dental products and services. The company offers a variety of products, including custom-made crowns and bridges, clear aligners, thermoforming sheets, and pediatric dental solutions. With a strong presence in the global market, Laxmi Dental operates several divisions, including Illusion Dental Lab, Laxmi Dental Export, Illusion Aligners, Taglus, and Kids-e-Dental, each focusing on different aspe...Read More
Laxmi Dental Limited, established in 2004 and based in Mumbai, India, is a prominent player in the dental industry, providing a comprehensive range of dental products and services. The company offers a variety of products, including custom-made crowns and bridges, clear aligners, thermoforming sheets, and pediatric dental solutions. With a strong presence in the global market, Laxmi Dental operates several divisions, including Illusion Dental Lab, Laxmi Dental Export, Illusion Aligners, Taglus, and Kids-e-Dental, each focusing on different aspects of dental care and products. The company operates six manufacturing facilities in India, along with five supporting facilities, and exports its products to over 90 countries, serving more than 22,000 dental professionals across India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1040 Cr.
Stock P/E 41
P/B 4.5
Current Price ₹189.2
Book Value ₹ 41.9
Face Value 2
52W High ₹509.8
Dividend Yield 0%
52W Low ₹ 155.7
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 |
| Other Income | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 |
| Total Income | 48 | 55 | 60 | 58 | 62 | 62 | 67 | 75 | 68 |
| Total Expenditure | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 11 | 14 | 13 | 9 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | -0 | 7 | 0 | 0 | 0 | 0 | 0 | -6 |
| Profit Before Tax | -0 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | -1 |
| Provision for Tax | -1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | -2 |
| Profit After Tax | 1 | 6 | 14 | 4 | 4 | 4 | 7 | 8 | 1 |
| Adjustments | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit After Adjustments | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 |
| Adjusted Earnings Per Share | 0.2 | 2.7 | 6 | 2.1 | 0.9 | 0.8 | 1.5 | 1.6 | 0.4 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 137 | 162 | 194 | 239 | 265 |
| Other Income | 1 | 2 | 2 | 3 | 8 |
| Total Income | 138 | 164 | 195 | 242 | 272 |
| Total Expenditure | 131 | 152 | 169 | 196 | 225 |
| Operating Profit | 7 | 12 | 26 | 46 | 47 |
| Interest | 4 | 5 | 6 | 6 | 1 |
| Depreciation | 8 | 11 | 12 | 15 | 16 |
| Exceptional Income / Expenses | -9 | -0 | -0 | 7 | -6 |
| Profit Before Tax | -15 | -4 | 9 | 32 | 24 |
| Provision for Tax | 2 | 0 | -9 | 6 | 4 |
| Profit After Tax | -17 | -4 | 18 | 25 | 20 |
| Adjustments | -1 | 0 | 7 | 6 | 4 |
| Profit After Adjustments | -18 | -4 | 25 | 32 | 23 |
| Adjusted Earnings Per Share | -6.6 | -1.4 | 8.9 | 5.8 | 4.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 23% | 20% | 0% | 0% |
| Operating Profit CAGR | 77% | 87% | 0% | 0% |
| PAT CAGR | 39% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -53% | NA% | NA% | NA% |
| ROE Average | 21% | 20% | -30% | -30% |
| ROCE Average | 25% | 16% | 7% | 7% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 21 | 18 | 42 | 209 |
| Minority's Interest | 2 | 2 | 2 | 0 |
| Borrowings | 10 | 11 | 15 | 11 |
| Other Non-Current Liabilities | 10 | 8 | -4 | 2 |
| Total Current Liabilities | 59 | 58 | 66 | 57 |
| Total Liabilities | 103 | 97 | 123 | 278 |
| Fixed Assets | 39 | 39 | 45 | 51 |
| Other Non-Current Assets | 4 | 4 | 9 | 41 |
| Total Current Assets | 60 | 53 | 64 | 187 |
| Total Assets | 103 | 97 | 123 | 278 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | -11 | -14 | -10 | -16 |
| Cash Flow from Operating Activities | -2 | 15 | 8 | 44 |
| Cash Flow from Investing Activities | 3 | -9 | -11 | -29 |
| Cash Flow from Financing Activities | -4 | -2 | -3 | 111 |
| Net Cash Inflow / Outflow | -3 | 4 | -5 | 125 |
| Closing Cash & Cash Equivalent | -14 | -10 | -16 | 109 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | -6.63 | -1.43 | 8.94 | 5.78 |
| CEPS(Rs) | -3.13 | 2.36 | 10.78 | 7.35 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 3.41 | 2.23 | 11.13 | 37.54 |
| Core EBITDA Margin(%) | 4.49 | 6.11 | 12.6 | 17.84 |
| EBIT Margin(%) | -7.61 | 0.46 | 7.27 | 15.89 |
| Pre Tax Margin(%) | -10.75 | -2.64 | 4.4 | 13.31 |
| PAT Margin (%) | -12.48 | -2.75 | 9.27 | 10.61 |
| Cash Profit Margin (%) | -6.35 | 4.05 | 15.44 | 16.89 |
| ROA(%) | -16.65 | -4.46 | 16.3 | 12.64 |
| ROE(%) | -180.94 | -57.01 | 96.95 | 21.4 |
| ROCE(%) | -20.54 | 1.5 | 21.04 | 24.97 |
| Receivable days | 54.32 | 46.05 | 42.73 | 47 |
| Inventory Days | 78.69 | 60.66 | 46.15 | 33.1 |
| Payable days | 245.23 | 214.61 | 144.21 | 152.61 |
| PER(x) | 0 | 0 | 0 | 76.82 |
| Price/Book(x) | 0 | 0 | 0 | 11.83 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.29 | 0.26 | 0.27 | 9.8 |
| EV/Core EBITDA(x) | 5.44 | 3.46 | 2.03 | 50.94 |
| Net Sales Growth(%) | 0 | 18.11 | 19.75 | 23.53 |
| EBIT Growth(%) | 0 | 107.18 | 1780.75 | 170.09 |
| PAT Growth(%) | 0 | 73.96 | 503.26 | 41.44 |
| EPS Growth(%) | 0 | 78.37 | 723.64 | -35.33 |
| Debt/Equity(x) | 1.41 | 1.77 | 0.99 | 0.06 |
| Current Ratio(x) | 1.01 | 0.92 | 0.98 | 3.3 |
| Quick Ratio(x) | 0.51 | 0.5 | 0.6 | 2.97 |
| Interest Cover(x) | -2.42 | 0.15 | 2.54 | 6.16 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 41.7 | 41.7 | 41.7 | 41.7 | 41.77 |
| FII | 34.24 | 33.59 | 32.39 | 32.45 | 31.21 |
| DII | 12.86 | 14.31 | 11.85 | 10.83 | 10.52 |
| Public | 11.19 | 10.4 | 14.06 | 15.02 | 16.5 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 2.29 | 2.29 | 2.29 | 2.29 | 2.3 |
| FII | 1.88 | 1.85 | 1.78 | 1.78 | 1.72 |
| DII | 0.71 | 0.79 | 0.65 | 0.6 | 0.58 |
| Public | 0.62 | 0.57 | 0.77 | 0.83 | 0.91 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
